In 2002, the National Rosacea Society assembled an expert committee to develop the first
standard classification of rosacea. This original classification was intended to be updated as …

Background The exact prevalence and incidence of rosacea remain unknown, although it is
a common condition associated with severe noncutaneous diseases. Objectives To perform …

Sulfoximines have been largely disregarded in medicinal chemistry for a long time.
However, recently, they have risen to the apparent level of stardom on the drug discovery …

Key Clinical Points Rosacea Rosacea is a common, chronic facial skin disease that can
have an adverse effect on quality of life; it affects more women than men. The diagnosis is …

Background Rosacea is currently diagnosed by consensus‐defined primary and secondary
features and managed by subtype. However, individual features (phenotypes) can span …

Rosacea is a common chronic inflammatory skin disease of the central facial skin and is of
unknown origin. Currently, two classifications of rosacea exist that are based on either …

Inflammatory dermatosis is characterized by persistent inflammatory infiltration and hard
repair of diseased skin. As a member of the human innate immune cells, macrophages …

Background Neither dupilumab-associated facial erythema nor neck erythema was reported
in phase 3 clinical trials for the treatment of atopic dermatitis, but there have been a number …

In 2017, a National Rosacea Society Expert Committee developed and published an
updated classification of rosacea to reflect current insights into rosacea pathogenesis …

Rosacea is a chronic relapsing inflammatory skin disease with high prevalence worldwide.
Recent research suggests that dysregulation of innate and adaptive immune pathways as …